Computing stability effects of mutations in human superoxide dismutase 1.

Area of Science:

• Biochemistry
• Computational Biology
• Structural Biology

Background:

• Protein stability is crucial for understanding disease mechanisms and linking genotypes to phenotypes.
• Superoxide Dismutase 1 (SOD1) is a well-characterized protein ideal for studying mutation effects due to its stability and available structural data.

Purpose of the Study:

• To evaluate the accuracy of five computational methods (CUPSAT, I-Mutant2.0, I-Mutant3.0, PoPMuSiC, SDM) for predicting SOD1 mutation stability changes.
• To assess the impact of structural sensitivity and data resolution on prediction accuracy.
• To determine the significance of batch computations versus single mutant calculations for genotype-phenotype gap bridging.

Main Methods:

• Computed stability changes for SOD1 mutations using five distinct computational tools.
• Analyzed the correlation between computational predictions and experimental data for SOD1 monomers and dimers.
• Investigated the influence of structural variations (resolution, protein copies) and protein interactions on prediction outcomes.

Main Results:

• A high correlation (r = 0.82) was observed between experimental data for SOD1 dimers and monomers, suggesting additive mutation effects.
• PoPMuSiC demonstrated the highest accuracy, with a typical Mean Absolute Error (MAE) of ~1 kcal/mol and a correlation coefficient (r) of ~0.5.
• Method performance was largely independent of structural sensitivity; more accurate methods showed lower sensitivity to structural variations.
• Batch computations proved more significant than single mutant calculations for large-scale analyses, effectively bridging the genotype-phenotype gap.

Conclusions:

• Computational prediction of protein stability changes is a valuable tool for disease research and genotype-phenotype correlation.
• PoPMuSiC is a highly accurate method for predicting SOD1 stability changes.
• Batch computations offer a robust approach for large-scale proteomic analyses, particularly in disease-related studies.
• Future method development should address challenges in modeling glycine mutations.